Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination., An Issue of Clinics in Liver Disease

In this issue of Clinics in Liver Disease, guest editor Robert G. Gish brings his considerable expertise to the topic of Hepatitis B and Hepatitis D. The articles provide state-of-the-art clinical summaries of the advances in Hepatitis B and D, with emphasis on HBV viro-immunology, novel assays, new targets, and tests for HBV and HDV, and more. INDICE: Chronic Hepatitis B: Treat all Who Are Viremic?Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?What Is the Current Status of Hepatitis B Virus Viro-Immunology?Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis BOverview of New Targets for Hepatitis B Virus: Immune Modulators, Interferons, Bifunctional Peptides, Therapeutic Vaccines and BeyondNovel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid PolymersTargeting Hepatitis B Virus DNA Using Designer Gene EditorsMaternal-to-Child Transmission of Hepatitis B Virus and Hepatitis Delta VirusState of the Art: Test all for Anti-Hepatitis D Virus and Reflex to Hepatitis D Virus RNA Polymerase Chain Reaction QuantificationTriple Threat: HDV, HBV, HIV CoinfectionWhat Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New OptionsTest All for Hepatitis B Virus: Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible

• ISBN: 978-0-323-93947-8
• Editorial: Elsevier
• Encuadernacion: Cartoné
• Páginas: 240
• Fecha Publicación: 04/10/2023
• Nº Volúmenes: 1
• Idioma: Inglés